Correlation Between Century Therapeutics and Cellectar Biosciences
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Cellectar Biosciences, you can compare the effects of market volatilities on Century Therapeutics and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Cellectar Biosciences.
Diversification Opportunities for Century Therapeutics and Cellectar Biosciences
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Century and Cellectar is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Cellectar Biosciences go up and down completely randomly.
Pair Corralation between Century Therapeutics and Cellectar Biosciences
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Cellectar Biosciences. In addition to that, Century Therapeutics is 1.14 times more volatile than Cellectar Biosciences. It trades about 0.0 of its total potential returns per unit of risk. Cellectar Biosciences is currently generating about 0.01 per unit of volatility. If you would invest 184.00 in Cellectar Biosciences on September 1, 2024 and sell it today you would lose (30.00) from holding Cellectar Biosciences or give up 16.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Cellectar Biosciences
Performance |
| Timeline |
| Century Therapeutics |
| Cellectar Biosciences |
Century Therapeutics and Cellectar Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Cellectar Biosciences
The main advantage of trading using opposite Century Therapeutics and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
| Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |